Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for skull base tumors.

J A Jane1, G A Helm

  • 1Department of Neurosurgery, University of Virginia, Charlottesville 22908, USA.

Neurosurgery Clinics of North America
|November 18, 2000
PubMed
Summary

Gene therapy shows promise for skull base tumors, offering a potential first step toward targeted treatment. Advances in gene delivery and oncolytic viruses could improve efficacy and minimize side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidural Hematoma in Lacrosse.

The Physician and sportsmedicine·2016
Same author

Preoperative embolization of intracranial meningiomas: efficacy, technical considerations, and complications.

AJNR. American journal of neuroradiology·2014
Same author

Transforming growth factor-Beta binds reversibly in vitro to guglielmi detachable coils.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
Same author

ASSESSMENT OF THE NATURAL HISTORY OF ANTERIOR COMMUNICATING ANEURYSMS.

Journal of neurosurgery·2009
Same author

Bilateral intracavernous carotid artery pseudoaneurysms as a result of sellar reconstruction during the transsphenoidal resection of a pituitary macroadenoma: case report.

Minimally invasive neurosurgery : MIN·2009
Same author

Endovascular treatment of experimental aneurysms with use of fibroblast transfected with replication-deficient adenovirus containing bone morphogenetic protein-13 gene.

AJNR. American journal of neuroradiology·2008

Area of Science:

  • Oncology
  • Gene Therapy
  • Neurosurgery

Background:

  • Gene therapy is a rapidly advancing field in medicine.
  • Efficient gene delivery remains a challenge for treating brain tumors, often leading to recurrence.
  • Skull base tumors, frequently benign, present a unique therapeutic challenge.

Purpose of the Study:

  • To explore the potential of gene therapy for treating skull base lesions.
  • To discuss the advantages of oncolytic viruses for tumor propagation.
  • To highlight the feasibility of endovascular approaches for targeted delivery.

Main Methods:

  • Review of current gene therapy and viral vector technologies.
  • Discussion of endovascular delivery strategies for skull base tumors.
  • Exploration of transcriptional and transductional targeting for tumor specificity.

Main Results:

  • Oncolytic viruses show potential for treating skull base lesions.
  • Gene therapy may offer local control with reduced morbidity for benign tumors.
  • Endovascular approaches can achieve high vector concentrations in tumors.

Conclusions:

  • Gene therapy, particularly with oncolytic viruses, holds significant promise for skull base tumors.
  • Targeted delivery and advanced vector development are crucial for successful treatment.
  • Minimally invasive approaches combined with gene therapy could revolutionize skull base tumor treatment.

Related Experiment Videos